The NephroCheck® Test for AKI Risk Assessment
A single-use cartridge designed to detect biomarkers of acute kidney injury (AKI), TIMP-2 and IGFBP-7, the NephroCheck® Test System provides results in 20 minutes.
NephroCheck® Test Procedure
The test procedure involves the operator applying a fresh or thawed (i.e. previously frozen) clinical urine sample (mixed with labeled fluorescent conjugate) to the NephroCheck® Test Cartridge, and then inserting the test cartridge into the Astute140® Meter for incubation, reading, result calculation, and result display.
The Astute Medical NephroCheck® Test System is intended to be used in conjunction with clinical evaluation in patients who currently have or have had within the past 24 hours acute cardiovascular and or respiratory compromise and are ICU patients as an aid in the risk assessment for moderate or severe acute kidney injury (AKI) within 12 hours of patient assessment. The NephroCheck® Test System is intended to be used in patients 21 years of age or older.